Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

64 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Refractory gout: what is it and what to do about it?
Fels E, Sundy JS. Fels E, et al. Curr Opin Rheumatol. 2008 Mar;20(2):198-202. doi: 10.1097/BOR.0b013e3282f4eff5. Curr Opin Rheumatol. 2008. PMID: 18349751 Review.
OMERACT endorsement of measures of outcome for studies of acute gout.
Singh JA, Taylor WJ, Dalbeth N, Simon LS, Sundy J, Grainger R, Alten R, March L, Strand V, Wells G, Khanna D, McQueen F, Schlesinger N, Boonen A, Boers M, Saag KG, Schumacher HR, Edwards NL. Singh JA, et al. J Rheumatol. 2014 Mar;41(3):569-73. doi: 10.3899/jrheum.131246. Epub 2013 Dec 15. J Rheumatol. 2014. PMID: 24334651 Free PMC article.
Pegloticase for treating refractory chronic gout.
George RL Jr, Sundy JS. George RL Jr, et al. Drugs Today (Barc). 2012 Jul;48(7):441-9. doi: 10.1358/dot.2012.48.7.1813475. Drugs Today (Barc). 2012. PMID: 22844655 Review.
Bioaerosols and innate immune responses in airway diseases.
Hauswirth DW, Sundy JS. Hauswirth DW, et al. Curr Opin Allergy Clin Immunol. 2004 Oct;4(5):361-6. doi: 10.1097/00130832-200410000-00006. Curr Opin Allergy Clin Immunol. 2004. PMID: 15349034 Review.
Infusion-related reactions with pegloticase, a recombinant uricase for the treatment of chronic gout refractory to conventional therapy.
Baraf HS, Yood RA, Ottery FD, Sundy JS, Becker MA. Baraf HS, et al. J Clin Rheumatol. 2014 Dec;20(8):427-32. doi: 10.1097/RHU.0000000000000200. J Clin Rheumatol. 2014. PMID: 25417679 Free PMC article. Review.
Quality of life and disability in patients with treatment-failure gout.
Becker MA, Schumacher HR, Benjamin KL, Gorevic P, Greenwald M, Fessel J, Edwards L, Kawata AK, Frank L, Waltrip R, Maroli A, Huang B; Gout Natural History Study Group, Sundy JS. Becker MA, et al. J Rheumatol. 2009 May;36(5):1041-8. doi: 10.3899/jrheum.071229. Epub 2009 Mar 30. J Rheumatol. 2009. PMID: 19332629 Clinical Trial.
Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: results of a phase II randomized study.
Sundy JS, Becker MA, Baraf HS, Barkhuizen A, Moreland LW, Huang W, Waltrip RW 2nd, Maroli AN, Horowitz Z; Pegloticase Phase 2 Study Investigators. Sundy JS, et al. Arthritis Rheum. 2008 Sep;58(9):2882-91. doi: 10.1002/art.23810. Arthritis Rheum. 2008. PMID: 18759308 Clinical Trial.
64 results
Jump to page
Feedback